Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate a novel topical negative pressure (TNP) wound therapy device called the SNaP® (Smart Negative Pressure) Wound Care System for the treatment of lower extremity diabetic, venous and mixed aetiology leg wounds.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds

NCT00951080

Ulcers Wounds

COMPLETED NA

Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

NCT01623882

Diabetic Foot Ulcer

WITHDRAWN

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

NCT07032701

Skin Carcinoma

NOT_YET_RECRUITING NA

Safety and Efficacy of the Noxsano Wound Care Bandage

NCT04123093

Wound Heal Peripheral Artery Disease Ulcer, Leg +3 more

TERMINATED NA

The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer

NCT00958711

Diabetic Foot Ulcers

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Extremity Diabetic Leg Wounds Lower Extremity Venous Leg Wounds Lower Extremity Mixed Aetiology Leg Wounds

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SNaP® Wound Care System

Intervention Type DEVICE

Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SNaP® Wound Care System

Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has diabetic foot ulceration, venous ulcer, or mixed aetiology ulcer with a surface area \<100 cm2 and \<10 cm in widest diameter on lower extremity, but larger than 1 cm2 (venous and mixed aetiology ulcers will be defined by clinical exam of treating physician. Diabetic foot ulcers will be defined by clinical exam of the treating physician and as lower extremity ulcers in patients with a diagnosis of diabetes, but without venous stasis disease).
* Wound present for \>30 days.
* Patient has wound in location amenable to creation of airtight seal around wound using TNP dressings.
* Patient is able to comply with study protocol requirements.
* Patient is able to understand and provide written consent.

Exclusion Criteria

* Patient has evidence of wound infection in the opinion of the physician.
* Patient has a thick eschar that persists after wound debridement.
* Patient has an HbA1C \>12%.
* Patient has ulcers due to inflammatory conditions such as pyoderma gangrenosum, rheumatoid arthritis, vasculitis, cryoglobulinaemia, necrobiosis lipoidica, panniculitis, lupus erythematosus, scleroderma, or calcinosis.
* Patient has untreated osteomyelitis.
* Patient has any other condition that, in the opinion of the investigator, makes the patient inappropriate to take part in this study.
* Patient is allergic to the wound care device or occlusive dressing.
* Patient has exposed blood vessels.
* Patient is pregnant or pregnancy is suspected.
* Patient is actively participating in other clinical trials that may interfere with their participation in this study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No